Pharmacological correction of L-NAME-induced oxide deficiency with derivatives of 3-(2,2,2-trimethylhydrazinium) propionate

Pharmacological correction of endothelial dysfunction using ademethionin and taurine

Khadieva, T. A.
Pokrovskaya, T. G.
Belousova, Y. V.

January 2019

It is noted that ademethionine and taurine have an endothelioprotective effect because of their abil...

Pharmacotherapeutic strategies for endothelial dysfunction correction with use of statines in syndrome of systemic inflammatory response

Denisiuk., T. A.

January 2017

The ways of pharmacological correction of cardiovascular complications in the syndrome of the system...

Use of L-arginine immobilised on activated carbon for pharmacological correction of endothelial disfunction

Shakhno, E. A.
Savitskaya, T. A.
Pokrovskaya, T. G.
Yakushev, V. I.
Pokrovskii, M. V.

January 2016

For the first time a complex of L-arginine sodium salt of sulfate of cellulose acetate on activated ...

Pharmacological correction of L-NAME-induced oxide deficiency with derivatives of 3-(2,2,2-trimethylhydrazinium) propionate

Skachilova, S. Y.
Kesarev, O. G.
Danilenko, L. M.
Bystrova, N. A.
Dolzhikov, A. A.

May 2020

This paper deals with the study of correction of L-NAME-induced endothelial dysfunction by means of ...

PHARMACOLOGICAL CORRECTION OF L-NAME-INDUCED OXIDE DEFICIENCY WITH DERIVATIVES OF 3-(2,2,2- TRIMETHYLHYDRAZINIUM) PROPIONATE

Skachilova, Sophiya Ya.
Kesarev, Oleg
Danilenko, Lyudmila
Bystrova, Natalya
Dolzhikov, Alexandr
Nikolaev, Sergej

March 2016

This paper deals with the study of correction of L-NAME-induced endothelial dysfunction by means of ...

Pharmacological protection of the ischemic myocardium by derivatives of 3-(2,2,2-trimethylhydrazinium) propionate and evaluation of their antioxidant activity

Skachilova, S. Y.
Danilenko, L. M.
Kesarev, O. G.
Kochkarov, I. S.

January 2015

The paper presents results of a study of antioxidant (in vitro) and anti-ischemic effect of a number...

Method of correction of endothelial dysfunction with combination of ademetionine and taurine

Khadieva, T. A.
Dovgan, A. P.
Pokroskaya, T. G.

January 2016

In the experiment, was made a simulation of endothelial dysfunction in male rats of Wistar-line byin...

Endothelioprotective property of the combination of the thioctic acid and rosuvastatin shown in the endothelial dysfunction models

Molchanova, O. V.
Pokrovskaya, T. G.
Povetkin, S. V.
Reznikov, K. M.

January 2016

During the experiment, the modeling of endothelial dysfunction of male rats was performed by intrape...

Pharmacological efficacy of an inhibitor of arginase-2 KUD975 with L-NAME-induced endothelial dysfunction

Kudryavtsev, K. V.
Korokin, M. V.
Gudyrev, O. S.

January 2017

The study of endotelio- and cardioprotective activity of finished dosage forms - tablets, film-coate...

The study of the endothelial protective properties of the L-norvaline combination with mexidol in the simulation of L-NAME-induced NO deficiency

Konovalova, E. A.
Chernomortseva, E. S.

January 2019

The endothelium is considered as a target for the prevention and treatment of pathological processes...

The cardio- and endothelial protective effects of ethyl methyl hydroxyl pyridine malate in modeling L-name induced nitric oxide deficiency

Kolesnichenko, P. D.
Shcheblykin, D. V.
Demidenko, A. N.
Reznikov, K. M.
Alhamzah Muhi Aldeen Azeez
Zhuchenko, M. A.
Demchenko, S. A.

January 2019

Currently, endothelial dysfunction is considered as a predictor of a number of pathologies, includin...

Evaluation of pharmacological correction of L-NAME-induced endothelial dysfunction, platelet aggregation and venous tone with diosmin detralex 1000 mg

Lukyanova, Y. S.
Kolesnichenko, P. D.
Gureev, V. V.
Zhilinkova, L. A.

January 2018

Chronic venous diseases are one of the urgent problems of modern medicine. Recent studies have shown...

Doxorubicin-associated Cardiomyopathy: New Approaches to Pharmacological Correction Using 3-(2,2,2-trimethylhydrazinium) Propionate Derivatives

Danilenko, L. M.

January 2018

The cardioprotective effect of the derivatives (nicotinate, 5-hydroxynicotinate) of 3-(2,2,2-trimeth...

Use of selective inhibitors of arginase 2 and tadalafil in combined compensation of homocysteine-induced endothelial dysfunction

Koklin, I. S.

January 2015

Use of selective inhibitors of arginase 2 in combination with tadalafil on in the course of modeling...

Pharmacological efficiency of statins and L-norvalin at an endotoxin-induced endothelial dysfunction

Ivlitskaya, I. L.
Korokin, M. V.
Loktionov, A. L.

January 2016

In the animals with endotoxin-induced endothelial dysfunction there were imbalance of contractile re...

Pharmacological correction of endothelial dysfunction using ademethionin and taurine

Khadieva, T. A.
Pokrovskaya, T. G.
Belousova, Y. V.

January 2019

It is noted that ademethionine and taurine have an endothelioprotective effect because of their abil...

Pharmacotherapeutic strategies for endothelial dysfunction correction with use of statines in syndrome of systemic inflammatory response

Denisiuk., T. A.

January 2017

The ways of pharmacological correction of cardiovascular complications in the syndrome of the system...

Use of L-arginine immobilised on activated carbon for pharmacological correction of endothelial disfunction

Shakhno, E. A.
Savitskaya, T. A.
Pokrovskaya, T. G.
Yakushev, V. I.
Pokrovskii, M. V.

January 2016

For the first time a complex of L-arginine sodium salt of sulfate of cellulose acetate on activated ...

Pharmacological correction of L-NAME-induced oxide deficiency with derivatives of 3-(2,2,2-trimethylhydrazinium) propionate

Skachilova, S. Y.
Kesarev, O. G.
Danilenko, L. M.
Bystrova, N. A.
Dolzhikov, A. A.

May 2020

This paper deals with the study of correction of L-NAME-induced endothelial dysfunction by means of ...

PHARMACOLOGICAL CORRECTION OF L-NAME-INDUCED OXIDE DEFICIENCY WITH DERIVATIVES OF 3-(2,2,2- TRIMETHYLHYDRAZINIUM) PROPIONATE

Skachilova, Sophiya Ya.
Kesarev, Oleg
Danilenko, Lyudmila
Bystrova, Natalya
Dolzhikov, Alexandr
Nikolaev, Sergej

March 2016

This paper deals with the study of correction of L-NAME-induced endothelial dysfunction by means of ...

Pharmacological protection of the ischemic myocardium by derivatives of 3-(2,2,2-trimethylhydrazinium) propionate and evaluation of their antioxidant activity

Skachilova, S. Y.
Danilenko, L. M.
Kesarev, O. G.
Kochkarov, I. S.

January 2015

The paper presents results of a study of antioxidant (in vitro) and anti-ischemic effect of a number...

Method of correction of endothelial dysfunction with combination of ademetionine and taurine

Khadieva, T. A.
Dovgan, A. P.
Pokroskaya, T. G.

January 2016

In the experiment, was made a simulation of endothelial dysfunction in male rats of Wistar-line byin...

Endothelioprotective property of the combination of the thioctic acid and rosuvastatin shown in the endothelial dysfunction models

Molchanova, O. V.
Pokrovskaya, T. G.
Povetkin, S. V.
Reznikov, K. M.

January 2016

During the experiment, the modeling of endothelial dysfunction of male rats was performed by intrape...

Pharmacological efficacy of an inhibitor of arginase-2 KUD975 with L-NAME-induced endothelial dysfunction

Kudryavtsev, K. V.
Korokin, M. V.
Gudyrev, O. S.

January 2017

The study of endotelio- and cardioprotective activity of finished dosage forms - tablets, film-coate...

The study of the endothelial protective properties of the L-norvaline combination with mexidol in the simulation of L-NAME-induced NO deficiency

Konovalova, E. A.
Chernomortseva, E. S.

January 2019

The endothelium is considered as a target for the prevention and treatment of pathological processes...

The cardio- and endothelial protective effects of ethyl methyl hydroxyl pyridine malate in modeling L-name induced nitric oxide deficiency

Kolesnichenko, P. D.
Shcheblykin, D. V.
Demidenko, A. N.
Reznikov, K. M.
Alhamzah Muhi Aldeen Azeez
Zhuchenko, M. A.
Demchenko, S. A.

January 2019

Currently, endothelial dysfunction is considered as a predictor of a number of pathologies, includin...

Evaluation of pharmacological correction of L-NAME-induced endothelial dysfunction, platelet aggregation and venous tone with diosmin detralex 1000 mg

Lukyanova, Y. S.
Kolesnichenko, P. D.
Gureev, V. V.
Zhilinkova, L. A.

January 2018

Chronic venous diseases are one of the urgent problems of modern medicine. Recent studies have shown...

Doxorubicin-associated Cardiomyopathy: New Approaches to Pharmacological Correction Using 3-(2,2,2-trimethylhydrazinium) Propionate Derivatives

Danilenko, L. M.

January 2018

The cardioprotective effect of the derivatives (nicotinate, 5-hydroxynicotinate) of 3-(2,2,2-trimeth...

Use of selective inhibitors of arginase 2 and tadalafil in combined compensation of homocysteine-induced endothelial dysfunction

Koklin, I. S.

January 2015

Use of selective inhibitors of arginase 2 in combination with tadalafil on in the course of modeling...

Pharmacological efficiency of statins and L-norvalin at an endotoxin-induced endothelial dysfunction

Ivlitskaya, I. L.
Korokin, M. V.
Loktionov, A. L.

January 2016

In the animals with endotoxin-induced endothelial dysfunction there were imbalance of contractile re...

Pharmacological correction of endothelial dysfunction using ademethionin and taurine

Khadieva, T. A.
Pokrovskaya, T. G.
Belousova, Y. V.

January 2019

It is noted that ademethionine and taurine have an endothelioprotective effect because of their abil...

Pharmacotherapeutic strategies for endothelial dysfunction correction with use of statines in syndrome of systemic inflammatory response

Denisiuk., T. A.

January 2017

The ways of pharmacological correction of cardiovascular complications in the syndrome of the system...

Use of L-arginine immobilised on activated carbon for pharmacological correction of endothelial disfunction

Shakhno, E. A.
Savitskaya, T. A.
Pokrovskaya, T. G.
Yakushev, V. I.
Pokrovskii, M. V.

January 2016

For the first time a complex of L-arginine sodium salt of sulfate of cellulose acetate on activated ...

Pharmacological correction of L-NAME-induced oxide deficiency with derivatives of 3-(2,2,2-trimethylhydrazinium) propionate

Abstract

Extracted data

Pharmacological correction of L-NAME-induced oxide deficiency with derivatives of 3-(2,2,2-trimethylhydrazinium) propionate

Abstract

Extracted data

Related items

Related items